Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity

INTRODUCTION: The efficacy and safety of ertugliflozin have not been well characterized in Asian populations with type 2 diabetes (T2D) and overweight or obesity as defined by the Chinese Diabetes Society [body mass index (BMI) ≥ 24 kg/m(2)]. METHODS: These post hoc analyses of pooled data from two...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Linong, Liu, Jie, Xu, Zhi Jin, Wei, Zhiqi, Zhang, Ruya, Malkani, Seema, Cater, Nilo B., Frederich, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944172/
https://www.ncbi.nlm.nih.gov/pubmed/36763328
http://dx.doi.org/10.1007/s13300-022-01345-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944172/
https://www.ncbi.nlm.nih.gov/pubmed/36763328
http://dx.doi.org/10.1007/s13300-022-01345-6

Ejemplares similares